Correlations between microRNAs and their target genes in skeletal myoblasts cell therapy for myocardial infarction

In the setting of ischemic heart disease in which revascularization therapies (both percutaneous and surgery) and pharmaceutical therapy are able to contribute to ventricular remodeling, nowadays we also have some indications about promising options to prevent or reverse the ventricular remodelling process and consequent heart failure. Stem cells provide an alternative curative intervention for the infarcted heart by compensating for the cardiomyocyte loss subsequent to myocardial injury.